3      0

311 - Pharmacology Update

‐ May 25, 2022 8:30am

Credits: None available.

This session provides valuable education for all nurses involved in nephrology care. Information is shared on newer drugs in kidney disease management and treatment, as well as drugs used to treat other disease processes that are now being used in individuals with kidney disease.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 5/25/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

There are no Planning Committee disclosures to declare.

Speaker Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
Upon completing this activity, the learner will be conversant on new medications being utilized in the care of nephrology patients.

Credits Available

Pharmacology Update